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Velocity (PSV) decreased from 40.97 m/s to 0.900.14 m/s. The 6- and 12-month PSV
values after DEB were significantly lower as compared to those obtained after CAS at the
same time intervals(Figure).
Conclusions: DEB treatment of ISR after CAS is feasible. Initial results show safety and
effectiveness.
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Background: After embolic protected CAS, new cerebral ischemic lesions have been
reported in up to 70 % of patients. There impact on long-term prognosis after CAS is
unknown. Aim of the study was to evaluate the impact of new asymptomatic cerebral
ischemic lesions, found in diffusion weighted magnetic resonance imaging (DWMRI)
after embolic protected carotid artery stenting (CAS), on long-term prognosis.
Methods: 837 consecutive patients who had an embolic protected CAS without
peri-procedural complications and had a DWMRI before and 24 hours after the procedure
were included. Cox Regression analyses were performed to identify independent risk
factors for long-term major adverse cerebral and cardiovascular events (MACCE)
including patient-, lesion-, and procedural characteristics as well as the result of the
DWMRI.
Results: The follow-up rate was 91 %. At a mean follow up of 779.5  535.8 days.
MACCE occurred in 6.04 % of the patients. Diabetes was the only significant independent
predictor for MACCE. Asymptomatic ischemic cerebral lesions after CAS were not
associated with MACCE during long-term FU.
Conclusions: In patients who underwent uncomplicated embolic protected CAS,only
diabetes was predictive for long-term MACCE, whereas asymptomatic ischemic embolic
events during CAS had no impact on long-term outcome.
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Background: Internal carotid artery stenosis (CS) degree is a poor marker of symptom
risk, and plaque morphology might play an important role. IVUS offers high-resolution
(axial0.12mm for 20MHz transducer) plaque imaging; nevertheless, phenotypic virtual
histology (VH-IVUS) carotid plaque classification was shown to be prone to between-
center and between-observer image interpretation variability.
Methods: We developed and implemented a novel Q-IVUS software-based algorithm for
detailed quantitative CS plaque VH-IVUS analysis to supplement the conventional
phenotypic plaque classification. Following inter-transducer and inter-observer reproduc-
ibility validation (n21, separate communication), we employed the QVH-IVUS ’peak’
algorithm (including standard - total component value per plaque cross-sectional area, PA;
and novel parameters - eg, minimal fibrous cap thickness, confluent necrotic core area,
thickness and arc) to evaluate 222 index CS lesions in 222 consecutive patients (age
47–83y, 62.6% men, 68.9% with h/o CS-attributable symptoms, S) presenting with
CS50% in the context of potential revascularization. Use of EPD for CS imaging (67%)
was left to operator (filters 
 ¾, proximal 
 1⁄4).
Results: Table; values are peakSEM per PA; abstract p values are for Total Asympt vs.
Total Sympt CS lesions. MLAminimal lumen area, ASarea stenosis, PBplaque
burden, FCfibrous cap, NCnecrotic core, FFfibro-fatty, Cadense calcium,
FTfibrotic).
Conclusions: QVH-IVUS ’peak’ image analysis of the carotid atherosclerotic plaque
revealed significant inter-group differences in novel QVH-IVUS plaque parameters,
including lower minimal FC thickness and higher confluent NC-area, -thickness and -arc,
and higher peak confluent Ca-area in S lesions. Further work will test the role of
QVH-IVUS ’peak’ image analysis algorithm in identifying the asymptomatic CS lesions
at risk of symptomatic transformation.
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Background: Chronic cerebrospinal venous insufficiency (CCSVI) characterized by
stenoses or obstructions of the internal jugular veins (IJV) and/or azygos vein (AZY), has
been reported to be associated with multiple sclerosis (MS). However, such association is
a matter of debate. The aim of our retrospective analysis was to determine the relationship
between the extent of extracranial venous pathology and clinical severity of MS.
Methods: We analyzed 50 consecutive patients (pts) with relapsing-remitting (32 pts)
and secondary progressive (18 pts) clinical course of MS (age 3810 years, M:F15:35)
scheduled for duplex ultrasound (DUS), invasive phlebography, and eventual endovas-
cular procedure of IJV and/or AZY. The extent of stenotic/obstructive process of IJV, and
AZY, or IJV reflux, were graded by combination of invasive phlebography and duplex
ultrasound as negative (group A), unilateral/focal stenosis/regurgitation (group B), or
bilateral/multifocal stenoses/regurgitation (group C). The clinical severity of MS was
evaluated by expanded disability disease scoring (EDSS). The study was approved by the
local scientific and ethical committee.
Results: Out of 50 analyzed pts (mean EDSS 3.72.4) there were 10 pts with negative
DUS and venous phlebography pathology (20%), 16 pts with unilateral/focal venous
pathology (32%), and 24 pts with bilateral/multifocal pathology (48%). The 20 cases were
treated by balloon angioplasty alone, whereas the stenting of at least one vein was required
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